$NXU
Nxu, Inc. Stock $nxu

$nxu Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121465924008802 Filed on May 10, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$4.000K
YoY Change
Cost Of Revenue	$21.00K
YoY Change
Gross Profit	-$17.00K
YoY Change
Gross Profit Margin	-425.0%
Selling, General & Admin	$5.923M	$10.72M
YoY Change	-44.76%	-43.5%
% of Gross Profit
Research & Development	$395.0K	$2.900M
YoY Change	-86.38%	317.64%
% of Gross Profit
Depreciation & Amortization	$270.0K	$142.0K
YoY Change	90.14%	158.18%
% of Gross Profit
Operating Expenses	$6.568M	$13.62M
YoY Change	-51.79%	-30.75%
Operating Profit	-$6.585M	-$13.62M
YoY Change	-51.66%	-30.75%
Interest Expense		$1.000K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$44.00K	$1.314M
YoY Change	-96.65%	-10578.47%
Pretax Income	-$6.541M	-$12.31M
YoY Change	-46.86%	-37.47%
Income Tax	$62.10M	$53.00M
% Of Pretax Income
Net Earnings	-$6.541M	-$12.31M
YoY Change	-46.86%	-37.47%
Net Earnings / Revenue	-163525.0%
Basic Earnings Per Share	-$0.91	$0.66
Diluted Earnings Per Share	-$0.91	-$0.66
COMMON SHARES
Basic Shares Outstanding	7.167M shares	18.73M shares
Diluted Shares Outstanding	7.167M shares	124.8K shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments		$12.90M
YoY Change
Cash & Equivalents	$9.181M	$12.90M
Short-Term Investments
Other Short-Term Assets		$1.054M
YoY Change
Inventory		$678.0K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$10.41M	$14.63M
YoY Change	-28.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.447M	$2.393M
YoY Change	85.83%
Goodwill
YoY Change
Intangibles		$10.00K
YoY Change
Long-Term Investments		$291.0K
YoY Change
Other Assets		$290.0K
YoY Change
Total Long-Term Assets	$11.16M	$3.416M
YoY Change	226.61%
TOTAL ASSETS
Total Short-Term Assets	$10.41M	$14.63M
Total Long-Term Assets	$11.16M	$3.416M
Total Assets	$21.56M	$18.05M
YoY Change	19.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$1.383M
YoY Change
Accrued Expenses		$761.0K
YoY Change
Deferred Revenue		$526.0K
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$119.0K
YoY Change
Total Short-Term Liabilities	$6.956M	$3.208M
YoY Change	116.83%
LONG-TERM LIABILITIES
Long-Term Debt		$6.442M
YoY Change
Other Long-Term Liabilities	$133.0K	$470.0K
YoY Change	-71.7%
Total Long-Term Liabilities	$133.0K	$6.912M
YoY Change	-98.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.956M	$3.208M
Total Long-Term Liabilities	$133.0K	$6.912M
Total Liabilities	$8.410M	$10.12M
YoY Change	-16.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$266.2M	-$230.9M
YoY Change	15.27%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.15M	$7.927M
YoY Change
Total Liabilities & Shareholders Equity	$21.56M	$18.05M
YoY Change	19.49%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$6.541M	-$12.31M
YoY Change	-46.86%	-37.47%
Depreciation, Depletion And Amortization	$270.0K	$142.0K
YoY Change	90.14%	158.18%
Cash From Operating Activities	-$3.487M	-$9.370M
YoY Change	-62.79%	78.37%
INVESTING ACTIVITIES
Capital Expenditures	$839.0K	$94.00K
YoY Change	792.55%
Acquisitions
YoY Change
Other Investing Activities		-$40.00K
YoY Change
Cash From Investing Activities	-$850.0K	-$134.0K
YoY Change	534.33%	-22.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$10.67M	$19.70M
YoY Change	-45.83%	477.26%
NET CHANGE
Cash From Operating Activities	-$3.487M	-$9.370M
Cash From Investing Activities	-$850.0K	-$134.0K
Cash From Financing Activities	$10.67M	$19.70M
Net Change In Cash	$6.335M	$10.20M
YoY Change	-37.88%	-606.36%
FREE CASH FLOW
Cash From Operating Activities	-$3.487M	-$9.370M
Capital Expenditures	$839.0K	$94.00K
Free Cash Flow	-$4.326M	-$9.464M
YoY Change	-54.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization		usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation		usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q1	us-gaap	Gross Profit GrossProfit		usd
CY2024Q1	us-gaap	Interest Expense InterestExpense		usd
CY2024Q1	us-gaap	Other Expenses OtherExpenses		usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2024Q1	NXU	Series B Stock Issued SeriesBStockIssued		usd
CY2024Q1	NXU	Conversion Of Series Convertible Preferred Stock ConversionOfSeriesConvertiblePreferredStock		usd
CY2024Q1	NXU	Common Stock Issued Under Stock Compensation Plans CommonStockIssuedUnderStockCompensationPlans		usd
CY2023Q1	NXU	Series B Stock Issued SeriesBStockIssued		usd
CY2024Q1	NXU	Share Based Goods And Nonemployee Services Transaction Modification Of Terms Incre ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncre		usd
CY2024Q1	NXU	Noncash Warrant Expense NoncashWarrantExpense		usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets		usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities		usd
CY2023Q1	NXU	Capitalized Patent Costs CapitalizedPatentCosts		usd
CY2024Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2023Q1	NXU	Proceeds From Atm Net Of Offering Costs ProceedsFromAtmNetOfOfferingCosts		usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2024Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	NXU	Debt Converted To Equity DebtConvertedToEquity		usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid		usd
CY2023Q1	NXU	Stockbased Compensation Expense Capitalized To Property And Equipment StockbasedCompensationExpenseCapitalizedToPropertyAndEquipment		usd
CY2023Q4	NXU	Charging Station Equipment Construction In Progress ChargingStationEquipmentConstructionInProgress		usd
CY2024Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2023Q1	NXU	Stockbased Compensation Capitalized To Property And Equipment StockbasedCompensationCapitalizedToPropertyAndEquipment		usd
CY2024Q1	NXU	Convertible Debt Issued During Period ConvertibleDebtIssuedDuringPeriod		usd
CY2024Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1		usd
CY2024Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2024Q1	NXU	Change In Fair Value Measurement Of Convertible Debt ChangeInFairValueMeasurementOfConvertibleDebt		usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2024Q1	NXU	Liability Warrants Exercised During Period LiabilityWarrantsExercisedDuringPeriod		usd
CY2024Q1	NXU	Fair Value Less Unpaid Principal Balance FairValueLessUnpaidPrincipalBalance		usd
CY2023Q4	NXU	Fair Value Less Unpaid Principal Balance FairValueLessUnpaidPrincipalBalance		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	1-41509
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	Nxu, Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	92-2819012
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9181000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2846000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	976000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	999000	usd
CY2024Q1	NXU	Notes Receivable From Related Party NotesReceivableFromRelatedParty	250000	usd
CY2023Q4	NXU	Notes Receivable From Related Party NotesReceivableFromRelatedParty	250000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	10407000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4095000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4447000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3865000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2951000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1507000	usd
CY2024Q1	NXU	Investment In Lynx InvestmentInLynx	3000000	usd
CY2023Q4	NXU	Investment In Lynx InvestmentInLynx	3000000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20000	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	729000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	772000	usd
CY2024Q1	us-gaap	Assets Assets	21564000	usd
CY2023Q4	us-gaap	Assets Assets	13259000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3498000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3371000	usd
CY2024Q1	NXU	Variable Share Settled Restricted Stock Units VariableShareSettledRestrictedStockUnits	1738000	usd
CY2023Q4	NXU	Variable Share Settled Restricted Stock Units VariableShareSettledRestrictedStockUnits	1334000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1720000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	864000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	40000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6956000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5609000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1300000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	688000	usd
CY2024Q1	NXU	Convertible Debt And Warrant Liability At Fair Value ConvertibleDebtAndWarrantLiabilityAtFairValue	21000	usd
CY2023Q4	NXU	Convertible Debt And Warrant Liability At Fair Value ConvertibleDebtAndWarrantLiabilityAtFairValue	65000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	133000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	233000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	8410000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	6595000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	279332000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	266302000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-266179000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-259638000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	13154000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6664000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21564000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13259000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4000	usd
CY2024Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	3000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	18000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	21000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-17000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	395000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3962000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6151000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9488000	usd
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	22000	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	34000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	6568000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	13484000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6585000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-13484000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1000	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	983000	usd
CY2024Q1	NXU	Gain On Convertible Debt And Warrant Liability GainOnConvertibleDebtAndWarrantLiability	44000	usd
CY2023Q1	NXU	Gain On Convertible Debt And Warrant Liability GainOnConvertibleDebtAndWarrantLiability	2281000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	17000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	44000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1314000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6541000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-12170000	usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-97.48
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-97.48
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7166858	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	124844	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6664000	usd
CY2024Q1	NXU	Common Stock Issued For Cash Under Atm CommonStockIssuedForCashUnderAtm	10712000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2319000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6541000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	13154000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9048000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4921000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5824000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	72000	usd
CY2023Q1	NXU	Exercise Of Warrants ExerciseOfWarrants	3300000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	546000	usd
CY2023Q1	NXU	Conversion Of Long Term Debt ConversionOfLongTermDebt	14482000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-12170000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	7927000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6541000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-12170000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	270000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	142000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2656000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5824000	usd
CY2023Q1	NXU	Share Based Goods And Nonemployee Services Transaction Modification Of Terms Incre ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncre	72000	usd
CY2023Q1	NXU	Noncash Warrant Expense NoncashWarrantExpense	984000	usd
CY2024Q1	NXU	Net Change In Operating Lease Assets And Liabilities NetChangeInOperatingLeaseAssetsAndLiabilities	24000	usd
CY2023Q1	NXU	Net Change In Operating Lease Assets And Liabilities NetChangeInOperatingLeaseAssetsAndLiabilities	-6000	usd
CY2024Q1	NXU	Gain On Fair Value Of Convertible Debt And Warrant Liability GainOnFairValueOfConvertibleDebtAndWarrantLiability	44000	usd
CY2023Q1	NXU	Gain On Fair Value Of Convertible Debt And Warrant Liability GainOnFairValueOfConvertibleDebtAndWarrantLiability	2281000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-23000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	185000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	580000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-43000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	182000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1065000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	64000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-100000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-169000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3487000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9370000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	839000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	94000	usd
CY2024Q1	NXU	Capitalized Patent Costs CapitalizedPatentCosts	11000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-850000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-94000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	12020000	usd
CY2024Q1	NXU	Proceeds From Atm Net Of Offering Costs ProceedsFromAtmNetOfOfferingCosts	10712000	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	9000000	usd
CY2023Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1864000	usd
CY2024Q1	NXU	Payments On Financing Liability PaymentsOnFinancingLiability	40000	usd
CY2023Q1	NXU	Payments On Financing Liability PaymentsOnFinancingLiability	40000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	546000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10672000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19662000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6335000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	10198000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2846000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2701000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9181000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12899000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
CY2023Q1	NXU	Debt Converted To Equity DebtConvertedToEquity	14481000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1861000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	149000	usd
CY2024Q1	NXU	Stockbased Compensation Expense Capitalized To Property And Equipment StockbasedCompensationExpenseCapitalizedToPropertyAndEquipment	67000	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-150 reverse stock split
CY2023Q1	NXU	Increase In Research And Development Costs IncreaseInResearchAndDevelopmentCosts	800000	usd
CY2023Q1	NXU	Increase In Stock Based Compensation Expense IncreaseInStockBasedCompensationExpense	100000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	6500000	usd
CY2024Q1	NXU	Net Cash Flows Used In Operating Activities NetCashFlowsUsedInOperatingActivities	3500000	usd
CY2024Q1	us-gaap	Cash Cash	9200000	usd
CY2024Q1	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	266200000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4447000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3865000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	270000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	140000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zPRnSquQcBe9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_861_z9FPMsDlcvab">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Due to uncertainties, actual results could differ from the estimates and assumptions used in preparation of the unaudited condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p>
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5514000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4763000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1168000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	898000	usd
CY2024Q1	NXU	Property And Equipment Excluding Construction In Progress Net PropertyAndEquipmentExcludingConstructionInProgressNet	4346000	usd
CY2023Q4	NXU	Property And Equipment Excluding Construction In Progress Net PropertyAndEquipmentExcludingConstructionInProgressNet	3865000	usd
CY2024Q1	NXU	Charging Station Equipment Construction In Progress ChargingStationEquipmentConstructionInProgress	101000	usd
CY2024Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	466000	usd
CY2023Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	372000	usd
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance	300000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	302000	usd
CY2024Q1	us-gaap	Prepaid Rent PrepaidRent	130000	usd
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	98000	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	102000	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	80000	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	125000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	976000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	999000	usd
CY2024Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	2044000	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	2501000	usd
CY2024Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	726000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	153000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	728000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	717000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	3498000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	3371000	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	59100000	usd
CY2024Q1	NXU	Operating Loss Carryforwards Expiration Date1 OperatingLossCarryforwardsExpirationDate1	2037
CY2017	NXU	Corporate Tax Rate CorporateTaxRate	0.21	pure
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1600000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	62100000	usd
CY2024Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-6541000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-12170000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7166858	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7166858	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	124844	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	124844	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-97.48
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-97.48
CY2024Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2024Q1	us-gaap	Liabilities Subject To Compromise Early Contract Termination Fees LiabilitiesSubjectToCompromiseEarlyContractTerminationFees	700000	usd
CY2024Q1	NXU	Legal Liability Payment Term LegalLiabilityPaymentTerm	P21M
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	2723000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	5824000	usd
CY2024Q1	NXU	Stockbased Compensation Capitalized To Property And Equipment StockbasedCompensationCapitalizedToPropertyAndEquipment	-67000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2656000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5824000	usd
CY2024Q1	NXU	Unrecognized Stockbased Compensation Related To Outstanding Awards UnrecognizedStockbasedCompensationRelatedToOutstandingAwards	8900000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y
CY2024Q1	NXU	Rsu Exchange Program Description RsuExchangeProgramDescription	the Company granted 1,117,457 Exchange Options to employees, which will vest in equal amounts on March 31, 2024 and June 30, 2024. The Exchange Options have a fair value of $0.7 million, which is equal to the fair value of the Exchanged RSUs at the Exchange Date, and as such no additional compensation cost was recorded as a result of the modification on the Exchange Date. Concurrently with the grant of the Exchange Options, the Company granted 553,236 additional stock options with a fair value of $0.3 million to employees, which will vest in equal amounts on June 30, 2024 and September 30, 2024.
CY2024Q1	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	Company has authority to issue is 5.0 billion shares, consisting of (1) 5.0 billion authorized shares of common stock, including (a) 4.0 billion authorized shares of Class A Common Stock, (b) 1.0 billion authorized shares of Class B common stock and (2) 10.0 million authorized shares of preferred stock, par value $0.0001 per share.
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	10000	usd
CY2024Q1	us-gaap	Convertible Debt ConvertibleDebt	10000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	55000	usd
CY2024Q1	NXU	Change In Fair Value Measurement ChangeInFairValueMeasurement	-44000	usd
CY2024Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	11000	usd
CY2024Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	21000	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	65000	usd
CY2024Q1	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	10000	usd
CY2023Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	10000	usd
CY2024Q1	NXU	Convertible Notes Contractual Principal Outstanding ConvertibleNotesContractualPrincipalOutstanding	10000	usd
CY2023Q4	NXU	Convertible Notes Contractual Principal Outstanding ConvertibleNotesContractualPrincipalOutstanding	10000	usd

Files In Submission

Name	View Source	Status
0001214659-24-008802-index-headers.html	Edgar Link	pending
0001214659-24-008802-index.html	Edgar Link	pending
0001214659-24-008802.txt	Edgar Link	pending
0001214659-24-008802-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nxu-20240331.xsd	Edgar Link	pending
nxu_logo.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
nxu-20240331_cal.xml	Edgar Link	unprocessable
nxu-20240331_def.xml	Edgar Link	unprocessable
nxu-20240331_lab.xml	Edgar Link	unprocessable
nxu-20240331_pre.xml	Edgar Link	unprocessable
r42624010q.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
r42624010q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NXU
Nxu, Inc. Stock $nxu

2024 Q1 Form 10-Q Financial Statement

#000121465924008802 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXU Nxu, Inc. Stock $nxu

2024 Q1 Form 10-Q Financial Statement

#000121465924008802 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXU
Nxu, Inc. Stock $nxu